Abdelgawad IA, Mossallam GI, Radwan NH, Elzawahry HM, Elhifnawy NM (2013) Can Glypican3 be diagnostic for early hepatocellular carcinoma among Egyptian patients? Asian Pac J Cancer Prev 14:7345–7349

Article  PubMed  Google Scholar 

Almåsbak H, Walseng E, Kristian A, Myhre M, Suso E, Munthe L et al (2015) Inclusion of an Igg1-Fc spacer abrogates efficacy of Cd19 Car T cells in a xenograft mouse model. Gene Ther 22:391–403

Article  PubMed  Google Scholar 

Ashrafizadeh M, Dai J, Torabian P, Nabavi N, Aref AR, Aljabali AA et al (2024) Circular RNAs in EMT-driven metastasis regulation: modulation of cancer cell plasticity, tumorigenesis and therapy resistance. Cell Mol Life Sci 81:1–25

Article  Google Scholar 

Asmamaw Dejenie T, Tiruneh GMM, Dessie Terefe G, Tadele Admasu F, Wale Tesega W, Chekol Abebe E (2022) Current updates on generations, approvals, and clinical trials of CAR T-cell therapy. Hum Vaccin Immunother 18:2114254

Article  PubMed  PubMed Central  Google Scholar 

Assadiasl S, Rajabinejad M, Soleimanifar N, Makiyan F, Azizi E, Rezaiemanesh A et al (2023) Micrornas-mediated regulation pathways in rheumatic diseases. Inflammopharmacology 31:129–144

Article  CAS  PubMed  Google Scholar 

Baessler A, Vignali DAA (2024) T cell exhaustion. Annu Rev Immunol 42:179–206

Article  PubMed  Google Scholar 

Befeler AS, Di Bisceglie AM (2002) Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 122:1609–1619

Article  PubMed  Google Scholar 

Brentjens RJ, Latouche J-B, Santos E, Marti F, Gong MC, Lyddane C et al (2003) Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nat Med 9:279–286

Article  CAS  PubMed  Google Scholar 

Bridgeman JS, Hawkins RE, Bagley S, Blaylock M, Holland M, Gilham DE (2010) The optimal antigen response of chimeric antigen receptors harboring the CD3ζ transmembrane domain is dependent upon incorporation of the receptor into the endogenous TCR/CD3 complex. J Immunol 184:6938–6949

Article  CAS  PubMed  Google Scholar 

Brocker T, Karjalainen K (1995) Signals through T cell receptor-zeta chain alone are insufficient to prime resting T lymphocytes. J Exp Med 181:1653–1659

Article  CAS  PubMed  Google Scholar 

Brudno JN, Kochenderfer JN (2018) Chimeric antigen receptor T-cell therapies for lymphoma. Nat Rev Clin Oncol 15:31–46

Article  CAS  PubMed  Google Scholar 

Burga RA, Thorn M, Point GR, Guha P, Nguyen CT, Licata LA et al (2015) Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T. Cancer Immunol Immunother 64:817–829

Article  CAS  PubMed  PubMed Central  Google Scholar 

Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E et al (2003) Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 125:89–97

Article  CAS  PubMed  Google Scholar 

Caruana I, Savoldo B, Hoyos V, Weber G, Liu H, Kim ES et al (2015) Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes. Nat Med 21:524–529

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caruso HG, Hurton LV, Najjar A, Rushworth D, Ang S, Olivares S et al (2015) Tuning sensitivity of car to EGFR density limits recognition of normal tissue while maintaining potent antitumor activity. Cancer Res 75:3505–3518

Article  CAS  PubMed  PubMed Central  Google Scholar 

Casadei-Gardini A, Scartozzi M, Tada T, Yoo C, Shimose S, Masi G et al (2021) Lenvatinib versus Sorafenib in first-line treatment of unresectable hepatocellular carcinoma: an inverse probability of treatment weighting analysis. Liver Int 41:1389–1397

Article  CAS  PubMed  Google Scholar 

Chailyan A, Marcatili P, Tramontano A (2011) The association of heavy and light chain variable domains in antibodies: implications for antigen specificity. FEBS J 278:2858–2866

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen C, Li K, Jiang H, Song F, Gao H, Pan X et al (2017) Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma. Cancer Immunol Immunother 66:475–489

Article  CAS  PubMed  Google Scholar 

Chen Q, Hu Q, Dukhovlinova E, Chen G, Ahn S, Wang C et al (2019) Photothermal therapy promotes tumor infiltration and antitumor activity of CAR T cells. Adv Mater 31:E1900192

Article  PubMed  PubMed Central  Google Scholar 

Chen L, He Y, Zhu J, Zhao S, Qi S, Chen X et al (2023) The roles and mechanism of m6a RNA methylation regulators in cancer immunity. Biomed Pharmacother 163:114839

Article  CAS  PubMed  Google Scholar 

Cheng A-L, Hsu C, Chan SL, Choo S-P, Kudo M (2020) Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma. J Hepatol 72:307–319

Article  CAS  PubMed  Google Scholar 

Cheshmi H, Mohammadi H, Akbari M, Nasiry D, Rezapour-Nasrabad R, Bagheri M et al (2023) Human placental mesenchymal stem cell-derived exosomes in combination with hyperbaric oxygen synergistically promote recovery after spinal cord injury in rats. Neurotox Res 41:431–445

Article  CAS  PubMed  Google Scholar 

Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D (2021) Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res 149:1–61

Article  CAS  PubMed  Google Scholar 

Chmielewski M, Abken H (2015) Trucks: the fourth generation of cars. Expert Opin Biol Ther 15:1145–1154

Article  CAS  PubMed  Google Scholar 

Commission GOONH (2022) Standard for diagnosis and treatment of primary liver cancer (2022 Edition). 临床肝胆病杂志 38:288–303

Craig AJ, Von Felden J, Garcia-Lezana T, Sarcognato S, Villanueva A (2020) Tumour evolution in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 17:139–152

Article  PubMed  Google Scholar 

Curio S, Jonsson G, Marinović S (2021) A summary of current NKG2D-based CAR clinical trials. Immunother Adv 1:Ltab018

Article  PubMed  PubMed Central  Google Scholar 

Daei Sorkhabi A, Mohamed Khosroshahi L, Sarkesh A, Mardi A, Aghebati-Maleki A, Aghebati-Maleki L et al (2023) The current landscape of CAR T-cell therapy for solid tumors: mechanisms, research progress, challenges and counterstrategies. Front Immunol 14:1113882

Article  PubMed  PubMed Central  Google Scholar 

Dai H, Tong C, Shi D, Chen M, Guo Y, Chen D et al (2020) Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial. Oncoimmunology 9:1846926

Article  PubMed  PubMed Central  Google Scholar 

De Saint Basile G, Ménasché G, Fischer A (2010) Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat Rev Immunol 10:568–579

Article  PubMed  Google Scholar 

Eder JP, Vande Woude GF, Boerner SA, Lorusso PM (2009) Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clin Cancer Res 15:2207–2214

Article  CAS  PubMed  Google Scholar 

Eshhar Z, Waks T, Gross G, Schindler DG (1993) Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc Natl Acad Sci 90:720–724

Article  CAS